Lupin Ltd Subsidiary Multicare Pharmaceuticals Philippines Inc. Buys Back Shares, Increasing Nanomi's Shareholding to 56.28%

Lupin Ltd announced that its subsidiary, Multicare Pharmaceuticals Philippines Inc. (MPPI), has bought back 2,813,811 equity shares from some of its existing shareholders. This buyback did not involve Nanomi, another subsidiary of Lupin Ltd, but resulted in an increase of Nanomi's shareholding in MPPI from 51% to 56.28%. MPPI is a Philippines-based entity engaged in trading, importing, marketing, and distributing pharmaceutical products and medical devices. The buyback was carried out using MPPI's retained earnings. MPPI's turnover as of March 31, 2025, was PHP 2,096.6 million with a net worth of PHP 1,265.5 million.